K Number
K182660
Device Name
GaltTWS
Manufacturer
Date Cleared
2019-05-30

(247 days)

Product Code
Regulation Number
870.1380
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The GaltTWS Stylet is a percutaneous catheter stylet placed inside a catheter, lead, or cannula to stiffen the device for placement or extraction.
Device Description
The GaltTWS stylet is comprised of a stainless steel twisted/braided wire of varying diameters (0.012-0.015 inch), and varying length (30-72cm). The GaltTWS stylet can be configured as a Twisted/Braided wire bonded to a hub, flushable hub, or connected to a flushable adjustable hub using the Galt Gateway Hemostasis Valve (K152528).
More Information

No
The device description and performance studies focus on the mechanical properties and biocompatibility of a simple wire stylet, with no mention of AI/ML or related concepts.

No
The device is described as a percutaneous catheter stylet used to stiffen a device for placement or extraction. Its function is to facilitate the delivery or removal of another medical device, rather than directly treat a disease or condition.

No

The device is described as a stylet used to stiffen other devices for placement or extraction, which is a procedural aid, not a diagnostic tool.

No

The device description explicitly states it is comprised of a stainless steel twisted/braided wire and can be bonded to a hub, indicating it is a physical hardware device.

Based on the provided information, the GaltTWS Stylet is not an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use: The intended use clearly states it's a "percutaneous catheter stylet placed inside a catheter, lead, or cannula to stiffen the device for placement or extraction." This describes a device used in vivo (within the body) to facilitate the placement or manipulation of other medical devices.
  • IVD Definition: In vitro diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. The GaltTWS Stylet does not perform any such tests on bodily samples.
  • Device Description: The description focuses on the physical components and configuration of the stylet itself, not on any reagents, test strips, or analytical components typically associated with IVDs.
  • Performance Studies: The performance studies described are bench tests and biocompatibility tests, which are relevant for in vivo medical devices, not typically for the analytical performance of an IVD.

Therefore, the GaltTWS Stylet is a medical device intended for use within the body, not an in vitro diagnostic device.

N/A

Intended Use / Indications for Use

The GaltTWS Stylet is a percutaneous catheter stylet placed inside a catheter, lead, or cannula to stiffen the device for placement or extraction.

Product codes

DRB

Device Description

The GaltTWS stylet is comprised of a stainless steel twisted/braided wire of varying diameters (0.012-0.015 inch), and varying length (30-72cm). The GaltTWS stylet can be configured as a Twisted/Braided wire bonded to a hub, flushable hub, or connected to a flushable adjustable hub using the Galt Gateway Hemostasis Valve (K152528).

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

The technological differences between the subject devices and predicate devices have been evaluated through bench and biocompatibility tests to provide evidence of substantial equivalence. The GaltTWS Stylet is substantially equivalent to the predicate devices based on comparisons of the devices functionality, compatibility, technological characteristics, and indications for use.

Functional Testing included the following:

  • Particulate Test
  • Mechanical Properties Test
  • Leak Test
  • Tortuous Path Test (In Vitro)

Additionally, accelerated aging was performed on the subject devices to an equivalent age of 4 years, and the physical and functional testing was repeated.

Biocompatibility testing was performed on the subject device in accordance with ISO 10993-1. Biocompatibility testing included the following:

  • Cytotoxicity (MEM Elution)
  • Sensitization (Magnusson Kligman)
  • Irritation (Intracutaneous injection)
  • Systemic Toxicity (Systemic injection)
  • Hemolysis (In Direct Contact)
  • Systemic Toxicity (Materials Mediated Pyrogen)
  • EO Residuals (EO, ECH, & EG)

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K992664, K982559, K152528

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 870.1380 Catheter stylet.

(a)
Identification. A catheter stylet is a wire that is run through a catheter or cannula to render it stiff.(b)
Classification. Class II (performance standards).

0

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the blue square is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

May 30, 2019 Galt Medical Corp. David Derrick Director of Quality and Regulatory Affairs 2220 Merritt Drive Garland, Texas 75087

Re: K182660

Trade/Device Name: GaltTWS Regulation Number: 21 CFR 870.1380 Regulation Name: Catheter Stylet Regulatory Class: Class II Product Code: DRB Dated: April 29, 2019 Received: April 30, 2019

Dear David Derrick:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part

1

801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

for

Matthew Hillebrenner Acting Division Director Division of Cardiac Electrophysiology, Diagnostics, and Monitoring Devices Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health

Enclosure

2

Indications for Use

510(k) Number (if known) K182660

Device Name GaltTWS Stylet

Indications for Use (Describe)

The GaltTWS Stylet is a percutaneous catheter stylet placed inside a catheter, lead, or cannula to stiffen the device for placement or extraction.

Type of Use (Select one or both, as applicable)

X Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

3

Application Date:November 13, 2018
Application Type:Traditional 510(k)
Applicant InformationGalt Medical Corporation
2220 Merritt Dr.
Garland, TX 75041
Phone: 214-778-1306
Fax: 972-271-4706
Official Contact:David Derrick
Director of Quality and Regulatory Affairs
Galt Medical Corporation
2220 Merritt Dr.
Garland, TX 75041
Phone: 214-778-1306
Fax: 972-271-4706
dderrick@galtmedical.com
Device Name:GaltTWS Stylet
Device Model Number:TBD
Classification Name:Catheter Stylet (DRB),
21 CFR 870.1380
Device Classification:Class II (Cardiovascular)
Predicate Device:TFX Medical Coated Stylet (K992664)
Guidewire (K982559)
Gateway Hemostasis Valve (152528)
Manufacturer:Galt Medical
2220 Merritt Drive
Garland, TX 75041
Phone: 214-778-5177

Establishment Registration Number: 1649395

Intended Use: The GaltTWS Stylet is a percutaneous catheter stylet placed inside a catheter, lead, or cannula to stiffen the device for placement or extraction.

Device Description: The GaltTWS stylet is comprised of a stainless steel twisted/braided wire of varying diameters (0.012-0.015 inch), and varying length (30-72cm). The GaltTWS stylet can be configured as a Twisted/Braided wire bonded to a hub, flushable

4

hub, or connected to a flushable adjustable hub using the Galt Gateway Hemostasis Valve (K152528).

Comparison of Technological Characteristics: The subject device GaltTWS Stylet and the predicate device TFX Medical Coated Catheter Stylet have same indication and are of similar design. The subject and predicate device are available in similar configurations.

Mfr. / ProductSubject DevicePredicate DevicePredicate DevicePredicate Device
Galt Medical /
GaltTWS StyletTFX Medical / TFX
Medical Coated
Catheter StyletGalt Medical /
GuidewireGalt Medical /
Gateway Hemostasis
Valve
510(k)
NumberN/AK992664K982559K152528
Device
Classification870.1380870.1380870.1340870.4290
Product CodeDRBDRBDQXDTL
Intended useThe Galt Medical
Corp. GaltTWS Stylet
is a percutaneous
catheter stylet placed
inside a catheter,
lead, or cannula to
stiffen the device for
placement or
extraction.The TFX Medical stylet
is intended for use in
conjunction with
catheters or other
devices, which require
the aid of a stylet to
render it stiff for
placement.The guidewire is
intended for use in
percutaneous
procedures to
introduce and
position catheter and
other interventional
devices within the
coronary and
peripheral
vasculature.The attachable Cath
Lab Hemostasis Valve
is indicated to
minimize blood loss
during introduction
of catheters,
guidewires and other
intravascular devices
into the vasculature.
DesignA stainless steel
twisted/braided wire
bonded to a hub,
flushable hub in a range
of sizes and lengths.A twisted/braided wire
bonded to a hub in a
range of sizes and
lengths.Guidewire with a tightly
wound coil over a
tapered core and a
ribbon. The ribbon is
welded to the coil at
both ends. The core is
welded to the coil at
the proximal end.Introducer with valved
hub and luer lock
connector
SizesDiameter - (0.012-0.015
inch)
Length (30-72cm)N/ADiameter - (0.014-0.065
inch)
Length (15-400cm)Maximum 8FR

5

Substantial Equivalence and Summary of Bench Testing: The technological differences between the subject devices and predicate devices have been evaluated through bench and biocompatibility tests to provide evidence of substantial equivalence. The GaltTWS Stylet is substantially equivalent to the predicate devices based on comparisons of the devices functionality, compatibility, technological characteristics, and indications for use.

Testing was conducted according to protocols based on international standards and Galt Medical requirements. Functional Testing included the following:

  • 0 Particulate Test
  • o Mechanical Properties Test
  • 0 Leak Test
  • 0 Tortuous Path Test (In Vitro)

Additionally, accelerated aging was performed on the subject devices to an equivalent age of 4 years, and the physical and functional testing was repeated.

Biocompatibility testing was performed on the subject device in accordance with ISO 10993-1. This was done in order to update the biocompatibility testing to current standards, and was not done as a result of any changes to the product. Biocompatibility testing included the following:

  • Cytotoxicity (MEM Elution) 0
  • Sensitization (Magnusson Kligman) 0
  • Irritation (Intracutaneous injection) O
  • 0 Systemic Toxicity (Systemic injection)
  • 0 Hemolysis (In Direct Contact)
  • 0 Systemic Toxicity (Materials Mediated Pyrogen)
  • o EO Residuals (EO, ECH, & EG)

Additionally the subject device was adopted into the existing ethylene oxide sterilization cycle for the Galt product cleared under K982559 & K152528.

Packaging of the subject device will remain unchanged from the Galt Medical Guidewire and Gateway Hemostasis Valve. Current packaging shelf life testing was provided in the predicate submissions.

Conclusion: The GaltTWS Stylet as designed and manufactured is determined to be substantially equivalent to the current marketed predicate devices.

End of Section